Peri-Procedural Infarction in Angioplasty vs. Surgery in the Left Main Coronary Artery

According to the EXCEL trial, peri-procedural infarction was more common after left main coronary artery surgery compared with angioplasty, and it was strongly associated with increased 3-year mortality after controlling all possible confounding variables. This increased mortality was only present in extensive infarctions with an increase in CK-MB ≥10×.

The EXCEL trial seems to want to challenge the SYNTAX trial as far as the number of sub-studies goes. Month after month we find a new published article derived from EXCEL trial data.

This particular work examined the 3-year rates of mortality among patients with and without peri-procedural infarction in a setting of left main coronary artery revascularization, who were randomized to angioplasty with an everolimus-eluting stent or surgery in the large-scale, multicenter, prospective, randomized EXCEL trial.

Per protocol, identical criteria were specified to define peri-procedural infarction for both strategies: CK-MB elevation >10× the upper reference limit within 72 h after the procedure, or >5× with new Q-waves, angiographic vessel occlusion, or loss of myocardial mass on imaging.


Read also: Next-Day Discharge after TAVR: Equally Safe for All Prosthesis?


The sub-study included a total of 1858 patients; the number of patients who met the criteria for peri-procedural infarction was 34 out of 935 (3.6%) patients in the angioplasty group and 56 out of 923 (6.1%) patients in the surgery group (odds ratio: 0.61; 95% confidence interval [CI]: 0.40–0.93; p = 0.02).

Periprocedural infarction was associated with anatomical complexity (SYNTAX score), chronic obstructive pulmonary disease, cross-clamp duration and total procedure duration, and not using antegrade cardioplegia.

Peri-procedural infarction almost tripled the 3-year mortality rates (hazard ratio [HR]: 2.63; 95% CI: 1.19-5.81; p = 0.02). Such effect was consistent for both revascularization strategies.


Read also: Functional Assessment of Lesions: Advances with MRI.


Peak post-procedure CK-MB ≥10× was clearly associated with mortality, whereas lesser degrees did not change the prognosis.

Conclusion

In the EXCEL trial, peri-procedural infarction was more common after surgery compared with angioplasty as treatment in the left main coronary artery, and it was strongly associated with increased 3-year mortality. Only extensive infarctions (CK-MB ≥10×) had an impact on prognosis.

Original title: Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for leftmain disease: an analysis from the EXCEL trial.

Reference: Ori Ben-Yehuda et al. European Heart Journal (2019) 0, 1–12.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...

Hybrid Coronary Revascularization versus Conventional Bypass Surgery in Left Main Coronary Artery Disease

Significant left main coronary artery (LMCA) disease continues to represent a therapeutic challenge, particularly in patients with complex multivessel disease and high SYNTAX scores,...

Comparison of strategies: NMA of IVUS, OCT, or angiography in complex lesions

Percutaneous coronary intervention (PCI) in complex lesions continues to represent a technical challenge in contemporary interventional cardiology. Angiography, although it remains the most widely...

Dynamic Coronary Roadmap: does it really help reduce contrast use?

Contrast-induced nephropathy remains a relevant complication of percutaneous coronary interventions (PCI), particularly in patients with multiple comorbidities and complex coronary anatomies. Dynamic Coronary Roadmap...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...

TEER plus optimal medical therapy versus medical therapy alone in functional mitral regurgitation

Mitral regurgitation (MR) is a highly prevalent valvular heart disease that, in advanced stages and when left untreated, is associated with reduced quality of...

Hybrid Coronary Revascularization versus Conventional Bypass Surgery in Left Main Coronary Artery Disease

Significant left main coronary artery (LMCA) disease continues to represent a therapeutic challenge, particularly in patients with complex multivessel disease and high SYNTAX scores,...